SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-005307
Filing Date
2020-05-06
Accepted
2020-05-06 09:17:42
Documents
90
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20200506x10q.htm   iXBRL 10-Q 1850617
2 EX-3.1 bpmc-20200331xex3d1.htm EX-3.1 133909
3 EX-10.1 bpmc-20200331xex10d1.htm EX-10.1 31961
4 EX-31.1 bpmc-20200331xex31d1.htm EX-31.1 18197
5 EX-31.2 bpmc-20200331xex31d2.htm EX-31.2 18235
6 EX-32.1 bpmc-20200331xex32d1.htm EX-32.1 13848
  Complete submission text file 0001558370-20-005307.txt   7696328

Data Files

Seq Description Document Type Size
7 EX-101.SCH bpmc-20200506.xsd EX-101.SCH 61851
8 EX-101.CAL bpmc-20200506_cal.xml EX-101.CAL 56485
9 EX-101.DEF bpmc-20200506_def.xml EX-101.DEF 216813
10 EX-101.LAB bpmc-20200506_lab.xml EX-101.LAB 513456
11 EX-101.PRE bpmc-20200506_pre.xml EX-101.PRE 405585
46 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20200506x10q_htm.xml XML 1273812
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 20851437
SIC: 2834 Pharmaceutical Preparations